AIMC Topic: Drug Development

Clear Filters Showing 211 to 220 of 333 articles

Machine Learning in Drug Discovery and Development Part 1: A Primer.

CPT: pharmacometrics & systems pharmacology
Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development. Here, we present a primer on the ML algorithms most commonly used in drug discovery and develop...

A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.

Molecular informatics
Drug-Target interaction (DTI) plays a crucial role in drug discovery, drug repositioning and understanding the drug side effects which helps to identify new therapeutic profiles for various diseases. However, the exponential growth in the genomic and...

Machine Learning for Cancer Drug Combination.

Clinical pharmacology and therapeutics
When treating multiple complex diseases, such as cancer, polytherapy may demonstrate efficiency than monotherapy. However, due to the multiplicative relationship between the number of drugs and cell lines vs. the number of combinations, it is impract...

Drug-target interaction prediction with tree-ensemble learning and output space reconstruction.

BMC bioinformatics
BACKGROUND: Computational prediction of drug-target interactions (DTI) is vital for drug discovery. The experimental identification of interactions between drugs and target proteins is very onerous. Modern technologies have mitigated the problem, lev...

Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical Pharmacology.

Clinical pharmacology and therapeutics
Understanding all aspects of developmental biology, or pediatric ontogeny, that affect drug therapy from the fetus to the adolescent child is the holy grail of pediatric scientists and clinical pharmacologists. The scientific community is now close t...

Key indicators of phase transition for clinical trials through machine learning.

Drug discovery today
A significant number of drugs fail during the clinical testing stage. To understand the attrition of drugs through the regulatory process, here we review and advance machine-learning (ML) and natural language-processing algorithms to investigate the ...

Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.

Small (Weinheim an der Bergstrasse, Germany)
Cancer is one of the leading causes of death worldwide, despite the large efforts to improve the understanding of cancer biology and development of treatments. The attempts to improve cancer treatment are limited by the complexity of the local milieu...

Graph Convolutional Neural Networks for Predicting Drug-Target Interactions.

Journal of chemical information and modeling
Accurate determination of target-ligand interactions is crucial in the drug discovery process. In this paper, we propose a graph-convolutional (Graph-CNN) framework for predicting protein-ligand interactions. First, we built an unsupervised graph-aut...